MIS416 Multiple Sclerosis Trial Results MStranslate June 28, 2017 MIS416, Research, Treatments On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...
